UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: ' | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 386.


't Hoen, PA; van der Wees, CG; Aartsma-Rus, A; Turk, R; Goyenvalle, A; Danos, O; Garcia, L; (2006) Gene expression profiling to monitor therapeutic and adverse effects of antisense therapies for Duchenne muscular dystrophy. Pharmacogenomics , 7 (3) pp. 281-297. 10.2217/14622416.7.3.281.


Al-Mahdawi, S; Pinto, RM; Varshney, D; Lawrence, L; Lowrie, MB; Hughes, S; Webster, Z; (2006) GAA repeat expansion mutation mouse models of Friedreich's ataxia exhibit oxidative stress leading to progressive neuronal cardiac pathology. Genomics , 88 (5) pp. 580-590.

Al-Shahrour, F; Minguez, P; Tárraga, J; Montaner, D; Alloza, E; Vaquerizas, JM; Conde, L; (2006) BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res , 34 (Web Serv) W472-W476. 10.1093/nar/gkl172.

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood , 108 (7) pp. 2182-2189. 10.1182/blood-2006-01-010249.

Ancliff, PJ; Blundell, MP; Cory, GO; Calle, Y; Worth, A; Kempski, H; Burns, S; (2006) Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. BLOOD , 108 (7) 2182 - 2189.

Arnould, S; Spanswick, VJ; Macpherson, JS; Hartley, JA; Thurston, DE; Jodrell, DI; Guichard, SM; (2006) Time-dependent cytotoxicity induced by SJG-136 (NSC 694501): influence of the rate of interstrand cross-link formation on DNA damage signaling. Mol Cancer Ther , 5 (6) pp. 1602-1609. 10.1158/1535-7163.MCT-06-0018.

Austin, S; Cohen, H; (2006) Antiphospholipid syndrome. Medicine , 34 (11) pp. 472-475. 10.1053/j.mpmed.2006.08.012.

Austin, SK; Lawrie, AS; Starke, RD; Scully, M; Machin, SJ; Cohen, H; Mackie, IJ; (2006) ADAMTS13 antibodies in patients with antiphospholipid antibodies. Presented at: 46th Annual Scientific Meeting of the British-Society-for-Haematology, Edinburgh, SCOTLAND.

Austin, SK; Starke, RD; Purdy, G; Lawrie, AS; Machin, SJ; Mackie, IJ; (2006) High affinity autoantibodies to ADAMTS13 in the antiphospholipid syndrome. In: BLOOD. (pp. 424A - 424A). AMER SOC HEMATOLOGY


Bates, AW; (2006) Dr Kahn's museum: obscene anatomy in Victorian London. J ROY SOC MED , 99 (12) 618 - 624.

Bates, AW; (2006) The worm, the demon and the virgin: the medieval theories on extraordinary generation: a study on the relations between theology, natural philosophy and medicine. MEDICAL HISTORY , 50 (3) pp. 410-411. Gold open access

Batten, P; Sarathchandra, P; Antoniw, JW; Tay, SS; Lowdell, MW; Taylor, PM; Yacoub, MH; (2006) Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: Relevance to tissue engineering human heart valves. TISSUE ENG , 12 (8) 2263 - 2273.

Behranwala, KA; Agarwal, T; El-Sharkawi, D; Shorvon, D; Chang, A; (2006) Laparoscopic resection of mucinous cystadenoma of appendix - A careful decision. SURG LAPARO ENDO PER , 16 (5) 347 - 348.

Bellodi, C; Kindle, K; Bernassola, F; Cossarizza, A; Dinsdale, D; Melino, G; Heery, D; (2006) A cytoplasmic PML mutant inhibits p53 function. CELL CYCLE , 5 (22) 2688 - 2692.

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic Function of Mutant Promyelocytic Leukemia (PML) and PML-Retinoic Acid Receptor-alpha. J BIOL CHEM , 281 (20) 14465 - 14473. 10.1074/jbc.M600457200. Gold open access

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Cytoplasmic function of mutant PML and PML-RARalpha. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 27 - 27). BLACKWELL PUBLISHING

Bellodi, C; Kindle, K; Bernassola, F; Dinsdale, D; Cossarizza, A; Melino, G; Heery, D; (2006) Role of cytoplasmic forms of PML and PML-RAR alpha in the response to therapy. In: TOXICOLOGY. (pp. 48 - 49). ELSEVIER IRELAND LTD

Benyo, Z; Gille, A; Bennett, CL; Clausen, BE; Offermanns, S; (2006) Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells. MOLECULAR PHARMACOLOGY , 70 (6) pp. 1844-1849. 10.1124/mol.106.030833.

Bergamaschi, D; Samuels, Y; Sullivan, A; Zvelebil, M; Breyssens, H; Bisso, A; Del Sal, G; (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nature Genetics , 38 (10) pp. 1133-1141. 10.1038/ng1879.

Betticher, DC; Martinelli, G; Radford, JA; Kaufmann, M; Dyer, MJS; Kaiser, U; Aulitzky, WE; (2006) Sequential high dose chemotherapy as initial treatment for aggressive sub-types of Non-Hodgkin Lymphoma: results of the international randomized phase III trial (MISTRAL). ANN ONCOL , 17 (10) 1546 - 1552. 10.1093/annonc/mdl153.

Bilancio, A; Okkenhaug, K; Camps, M; Emery, JL; Ruckle, T; Rommel, C; Vanhaesebroeck, B; (2006) Key role of the p110 delta isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110 delta function in B cells. BLOOD , 107 (2) pp. 642-650. 10.1182/blood.2005-07-3041.

Billottet, C; Grandage, VL; Gale, RE; Quattropani, A; Rommel, C; Vanhaesebroeck, B; Khwaja, A; (2006) A selective inhibitor of the p110 delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16. ONCOGENE , 25 (50) 6648 - 6659. 10.1038/sj.onc.1209670.

Birney, E; Andrews, D; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cox, T; (2006) Ensembl 2006. NUCLEIC ACIDS RESEARCH , 34 D556-D561. 10.1093/nar/gkj133.

Birney, E; Andrews, D; Caccamo, M; Chen, Y; Clarke, L; Coates, G; Cox, T; (2006) Ensembl 2006. Nucleic acids research. , 34 (Database)

Blay, J; Le Cesne, A; Whelan, J; Van Oosterom, A; Ray-Coquard, I; Judson, L; Hogendorn, P; (2006) Gefitinib in second line treatment of metastatic or locally advanced synovial sarcoma expressing HER1: A phase II trial of EORTC Soft Tissue and Bone Sarcoma Group. In: (pp. 9517-).

Bloor, AJ; Mackinnon, S; (2006) Cerebral tuberculosis post stem cell transplant. Eur J Haematol , 77 (5) 456-. 10.1111/j.1600-0609.2006.00718.x.

Bose, F; Fugazza, C; Casalgrandi, M; Capelli, A; Cunningham, JM; Zhao, Q; Jane, SM; (2006) Functional interaction of CP2 with GATA-1 in the regulation of dythroid promoters. MOLECULAR AND CELLULAR BIOLOGY , 26 (10) pp. 3942-3954. 10.1128/MCB.26.10.3942-3954.2006.

Boshoff, C; (2006) The biology of cancer. NATURE , 444 (7119) 549 - 549. 10.1038/444549a.

Bowen, D; Hyslop, A; Keenan, N; Groves, M; Culligan, D; Johnson, P; Shaw, A; (2006) Predicting erythroid response to recombinant erythropoietin plus granulocyte colony-stimulating factor therapy following a single subcutaneous bolus in patients with myelodysplasia. HAEMATOL-HEMATOL J , 91 (5) 709 - 710. Gold open access

Bridgewater, JA; Floore, A; Warmoes, MO; Veer Van't, L; (2006) Can gene expression microarray (GEM) provide a diagnosis in cases of carcinoma of unknown primary? J Clin Oncol , 24 (18_suppl) 20117-.

Brissault, B; Kichler, A; Leborgne, C; Danos, O; Cheradame, H; Gau, J; Auvray, L; (2006) Synthesis, characterization, and gene transfer application of poly(ethylene glycol-b-ethylenimine) with high molar mass polyamine block. Biomacromolecules , 7 (10) pp. 2863-2870. 10.1021/bm060499a.

Brissault, B; Leborgne, C; Guis, C; Danos, O; Cheradame, H; Kichler, A; (2006) Linear topology confers in vivo gene transfer activity to polyethylenimines. Bioconjug Chem , 17 (3) pp. 759-765. 10.1021/bc050287v.

Buchmueller, KL; Bailey, SL; Matthews, DA; Taherbhai, ZT; Register, JK; Davis, ZS; Bruce, CD; (2006) Physical and structural basis for the strong interactions of the -ImPy- central pairing motif in the polyamide f-ImPyIm. BIOCHEMISTRY-US , 45 (45) 13551 - 13565. 10.1021/bi061245c.

Burckbuchler, V; Wintgens, V; Lecomte, S; Percot, A; Leborgne, C; Danos, O; Kichler, A; (2006) DNA compaction into new DNA vectors based on cyclodextrin polymer: surface enhanced Raman spectroscopy characterization. Biopolymers , 81 (5) pp. 360-370. 10.1002/bip.20428.

Burton, C; Linch, D; Hoskin, P; Milligan, D; Dyer, MJ; Hancock, B; Mouncey, P; (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. Br J Cancer , 94 (6) pp. 806-813. 10.1038/sj.bjc.6602975.


Cannon, M; Cesarman, E; Boshoff, C; (2006) KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. BLOOD , 107 (1) 277 - 284. 10.1182/blood-2005-06-2350. Gold open access

Cappellini, MD; Cohen, A; Piga, A; Bejaoui, M; Perrone, S; Agaoglu, L; Aydinok, Y; (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. BLOOD , 107 (9) 3455 - 3462. 10.1182/blood-2005-08-3430.

Cardigan, R; Lawrie, A; Mackie, I; Williamson, L; (2006) Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor: reply. TRANSFUSION , 46 (6) 1059 - 1060.

Carmo, M; Faria, TQ; Falk, H; Coroadinha, AS; Teixeira, M; Merten, OW; Gény-Fiamma, C; (2006) Relationship between retroviral vector membrane and vector stability. J Gen Virol , 87 (Pt 5) pp. 1349-1356. 10.1099/vir.0.81302-0.

Carr, AJF; Tamai, TK; Young, LC; Ferrer, V; Dekens, MP; Whitmore, D; (2006) Light reaches the very heart of the zebrafish clock. CHRONOBIOLOGY INTERNATIONAL , 23 (1-2) 91 - 100. 10.1080/07420520500464395.

Carrasco, DR; Fenton, T; Sukhdeo, K; Protopopova, M; Enos, M; You, MJ; Di Vizio, D; (2006) The PTEN and INK4A/ARF tumor suppressors maintain myelolymphoid homeostasis and cooperate to constrain histiocytic sarcoma development in humans. Cancer Cell , 9 (5) pp. 379-390. 10.1016/j.ccr.2006.03.028.

Casado, E; Tabernero, J; Melichar, B; Bridgewater, J; Bennouna, J; Delord, J; Sopala, M; (2006) Patupilone in chemotherapy-pretreated patients with advanced colorectal cancer (CRC) receiving nutritional support and intensive diarrhea management: A phase I multicenter trial. J Clin Oncol , 24 (18_suppl) 3593-.

Cerdan, C; Bendall, SC; Wang, L; Stewart, M; Werbowetski, T; Bhatia, M; (2006) Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. NATURE MEDICINE , 12 (10) pp. 1113-1114. 10.1038/nm1006-1113.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Mutated telomeres sensitize tumor cells to anticancer drugs independently of telomere shortening and mechanisms of telomere maintenance. Oncogene , 25 (56) pp. 7411-7420. 10.1038/sj.onc.1209727.

Cerone, MA; Londoño-Vallejo, JA; Autexier, C; (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther , 5 (7) pp. 1669-1675. 10.1158/1535-7163.MCT-06-0033.

Chakraverty, R; Cote, D; Buchli, J; Cotter, P; Hsu, R; Zhao, GL; Sachs, T; (2006) An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J EXP MED , 203 (8) 2021 - 2031. 10.1084/jem.20060376. Green open access

Chantrain, CF; Bruwier, A; Brichard, B; Largent, V; Chapgier, A; Feinberg, J; Casanova, JL; (2006) Successful hematopoietic stem cell transplantation in a child with active disseminated Mycobacterium fortuitum infection and interferon-gamma receptor 1 deficiency. Bone Marrow Transplant , 38 (1) pp. 75-76. 10.1038/sj.bmt.1705399.

Chantry, AD; Snowden, JA; Craddock, C; Peggs, K; Roddie, C; Craig, JIO; Orchard, K; (2006) Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: A British Society of Blood and Marrow Transplantation registry study. BIOL BLOOD MARROW TR , 12 (12) 1310 - 1317. 10.1016/j.bbmt.2006.07.015.

Chapgier, A; Boisson-Dupuis, S; Jouanguy, E; Vogt, G; Feinberg, J; Prochnicka-Chalufour, A; Casrouge, A; (2006) Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genetics , 2 (8) e131 -. 10.1371/journal.pgen.0020131. Green open access

Chapgier, A; Wynn, RF; Jouanguy, E; Filipe-Santos, O; Zhang, S; Feinberg, J; Hawkins, K; (2006) Human complete Stat-1 deficiency is associated with defective type I and II IFN responses in vitro but immunity to some low virulence viruses in vivo. J Immunol , 176 (8) pp. 5078-5083.

Chiang, CLL; Ledermann, JA; Rad, AN; Katz, DR; Chain, BM; (2006) Hypochlorous acid enhances immunogenicity and uptake of allogeneic ovarian tumor cells by dendritic cells to cross-prime tumor-specific T cells. CANCER IMMUNOL IMMUN , 55 (11) 1384 - 1395. 10.1007/s00262-006-0127-9.

Chicken, DW; Clarke, B; Mosse, S; Falzon, M; Kocjan, G; Bown, S; Keshtgar, MRS; (2006) Rapid Intraoperative Diagnosis of Sentinel Node Metastases in Breast Cancer using Elastic Scattering Spectroscopy Scanning. In: (pp. p. 1026).

Chicken, DW; Kocjan, G; Falzon, M; Lee, AC; Douek, M; Sainsbury, R; Keshtgar, MRS; (2006) Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer. BRIT J SURG , 93 (5) 572 - 576. 10.1002/bjs.5289.

Cholongitas, E; Quaglia, A; Dhillon, AP; Patch, D; Burroughs, AK; (2006) Length versus width in liver biopsies. J HEPATOL , 44 (4) 822 - 823. 10.1016/j.jhep.2005.12.023.

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Patch, D; Dhillon, AP; Burroughs, AK; (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: LIVER TRANSPLANTATION. (pp. C60 - C60). JOHN WILEY & SONS INC

Cholongitas, E; Quaglia, A; Samonakis, D; Papatheodoridis, GV; Senzolo, M; Triantos, C; Patch, D; (2006) Patients with recurrent HCV infection and renal dysfunction after liver transplantation have slower fibrosis progression. In: JOURNAL OF HEPATOLOGY. (pp. S58 - S59). ELSEVIER SCIENCE BV

Cholongitas, E; Quaglia, A; Samonakis, D; Senzolo, M; Triantos, C; Patch, D; Leandro, G; (2006) Transjugular liver biopsy: how good is it for accurate histological interpretation? GUT , 55 (12) 1789 - 1794. 10.1136/gut.2005.090415.

Cholongitas, E; Samonakis, D; Manousou, P; Shusang, V; Dhillon, AP; Quaglia, A; Sharma, D; (2006) Randomised trial of tacrolimus monotherapy vs. tacrolimus/azathioprine/prednisolone after liver transplantation for HCV cirrhosis. LIVER TRANSPLANTATION , 12 (5) C61 - C61.

Cholongitas, E; Samonakis, D; Patch, D; Senzolo, M; Burroughs, AK; Quaglia, A; Dhillon, A; (2006) Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation , 81 (3) pp. 488-490. 10.1097/01.tp.0000196716.07188.c4.

Cholongitas, E; Senzolo, M; Standish, R; Marelli, L; Quaglia, A; Patch, D; Dhillon, AP; (2006) A systematic review of the quality of liver biopsy specimens. AM J CLIN PATHOL , 125 (5) 710 - 721. 10.1309/W3XCNT4HKFBN2G0B.

Cholongitas, E; Senzolo, M; Standish, R; Marelli, L; Quaglia, A; Patch, D; Dhillon, AP; (2006) A systematic review of the quality of liver biopsy specimens. Am J Clin Pathol , 125 (5) pp. 710-721. 10.1309/W3XC-NT4H-KFBN-2G0B.

Chong, G; Bhatnagar, A; Cunningham, D; Cosgriff, TM; Harper, PG; Steward, W; Bridgewater, J; (2006) Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer. Ann Oncol , 17 (3) pp. 437-442. 10.1093/annonc/mdj090.

Clamp, AR; Maenpaa, J; Cruickshank, D; Ledermann, J; Wilkinson, PM; Welch, R; Chan, S; (2006) SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel-irinotecan as first-line therapy for ovarian cancer. BRITISH JOURNAL OF CANCER , 94 (1) pp. 55-61. 10.1038/sj.bjc.6602910.

Clark, DA; Leong, HN; Nacheva, EP; Tsao, EHF; Griffiths, PD; Ward, KN; (2006) Chromosomal integration of human herpesvirus 6. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S104 - S104). ELSEVIER SCIENCE BV

Clark, DA; Nacheva, EP; Leong, HN; Brazma, D; Li, YT; Tsao, EHF; Buyck, HCE; (2006) Transmission of integrated human herpesvirus 6 through stem cell transplantation: Implications for laboratory diagnosis. In: JOURNAL OF INFECTIOUS DISEASES. (pp. 912 - 916). UNIV CHICAGO PRESS

Clark, DA; Tsao, EHF; Leong, HN; Ward, KN; Nacheva, EP; Griffiths, PD; (2006) Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells - Reply to Boutolleau et al. and Luppi et al. J INFECT DIS , 194 (7) 1021 - 1023.

Clements, MO; Godfrey, A; Crossley, J; Wilson, SJ; Takeuchi, Y; Boshoff, C; (2006) Lentiviral manipulation of gene expression in human adult and embryonic stem cells. TISSUE ENG , 12 (7) 1741 - 1751.

Coakley, M; Reddy, K; Mackie, I; Mallett, S; (2006) Transfusion triggers in orthotopic liver transplantation: A comparison of the thromboelastometry analyzer, the thromboelastogram, and conventional coagulation tests. J CARDIOTHOR VASC AN , 20 (4) 548 - 553. 10.1053/j.jvca.2006.01.016.

Collin, MP; Hart, DNJ; Jackson, GH; Cook, G; Cavet, J; Mackinnon, S; Middleton, PG; (2006) The fate of human Langerhans cells in hematopoietic stem cell transplantation. J EXP MED , 203 (1) 27 - 33. 10.1084/jem.20051787.

Conde, L; Vaquerizas, JM; Dopazo, H; Arbiza, L; Reumers, J; Rousseau, F; Schymkowitz, J; (2006) PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res , 34 (Web Serv) W621-W625. 10.1093/nar/gkl071.

Cook, G; Clark, RE; Crawley, C; Mackinnon, S; Russell, N; Thomson, K; Pearce, RM; (2006) The outcome of sibling and unrelated donor allogeneic stem cell transplantation in adult patients with acute myeloid leukemia in first remission who were initially refractory to first induction chemotherapy. BIOL BLOOD MARROW TR , 12 (3) 293 - 300. 10.1016/j.bbmt.2005.10.019.

Cooper, CS; Nicholson, AG; Foster, C; Dodson, A; Edwards, S; Fletcher, A; Roe, T; (2006) Nuclear overexpression of the E2F3 transcription factor in human lung cancer. LUNG CANCER , 54 (2) 155 - 162. 10.1016/j.lungcan.2006.07.005.

Corsini, E; Viviani, B; Birindelli, S; Gilardi, F; Torri, A; Codeca, I; Lucchi, L; (2006) Molecular mechanisms underlying mancozeb-induced inhibition of TNF-alpha production. TOXICOL APPL PHARM , 212 (2) 89 - 98. 10.1016/j.taap.2005.07.002.

Crespo, M; Villamor, N; Giné, E; Muntañola, A; Colomer, D; Marafioti, T; Jones, M; (2006) ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia. Clin Cancer Res , 12 (3 Pt 1) pp. 726-734. 10.1158/1078-0432.CCR-05-1531.

Cunningham, F; Rios, D; Griffiths, M; Smith, J; Ning, Z; Cox, T; Flicek, P; (2006) TranscriptSNPView: a genome-wide catalog of mouse coding variation. Nat Genet , 38 (8) 853-. 10.1038/ng0806-853a.

Cutillas, PR; Khwaja, A; Graupera, M; Pearce, W; Gharbi, S; Waterfield, M; Vanhaesebroeck, B; (2006) Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry. P NATL ACAD SCI USA , 103 (24) 8959 - 8964. 10.1073/pnas.0602101103. Gold open access


Dachs, GU; Steele, AJ; Coralli, C; Kanthou, C; Brooks, AC; Gunningham, SP; Currie, MJ; (2006) Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression. BMC Cancer , 6 , Article 280. 10.1186/1471-2407-6-280. Green open access

Damelin, M; Ooi, SKT; Bestor, TH; (2006) Combing over heritable gene silencing. NAT STRUCT MOL BIOL , 13 (2) 100 - 101. 10.1038/nsmb0206-100.

Danos, O; Svinartchouk, F; (2006) Dialysis-assisted two-dimensional gel electrophoresis. Electrophoresis , 27 (17) pp. 3475-3479. 10.1002/elps.200500036.

De Sousa, PA; Fletcher, JM; Ferrier, PM; Gardner, JO; Harkness, L; Dhanjal, S; Harper, J; (2006) Isolation of new therapeutically suitable human embryo stem cell lines without direct exposure to animal cell products. In: CELL TRANSPLANTATION. (pp. 541 - 541). COGNIZANT COMMUNICATION CORP

Deakin, JE; Papenfuss, AT; Belov, K; Cross, JGR; Coggill, P; Palmer, S; Sims, S; (2006) Evolution and comparative analysis of the MHC Class III inflammatory region. BMC GENOMICS , 7 , Article 281. 10.1186/1471-2164-7-281. Gold open access

Delgado, J; Cooper, N; Thomson, K; Duarte, R; Jarmulowicz, M; Cassoni, A; Kortaridis, P; (2006) The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. BIOL BLOOD MARROW TR , 12 (1) 75 - 83. 10.1016/j.bbmt.2005.08.036.

Delgado, J; Thomson, K; Russell, N; Ewing, J; Stewart, W; Cook, G; Devereux, S; (2006) Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study. BLOOD , 107 (4) 1724 - 1730. 10.1182/blood-2005-08-3372.

Descamps, MJL; Barrett, L; Groves, M; Yung, L; Birch, R; Murray, NMF; Linch, DC; (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J NEUROL NEUROSUR PS , 77 (9) 1087 - 1089. 10.1136/jnnp.2006.087577.

Desigan, S; Hall-Craggs, MA; Ho, CP; Eliahoo, J; Porter, JB; (2006) Degenerative disc disease as a cause of back pain in the thalassaemic population: a case-control study using MRI and plain radiographs. SKELETAL RADIOL , 35 (2) 95 - 102. 10.1007/s00256-005-0020-1.

Dhanjal, S; Kakourou, G; Saleh, N; Mamas, T; Doshi, A; Gotts, S; Nuttall, S; (2006) Preimplantation genetic diagnosis for retinoblastoma predisposition. In: JOURNAL OF MEDICAL GENETICS. (pp. S58 - S58). B M J PUBLISHING GROUP

Dhar, A; Johnson, KS; Novelli, MR; Bown, SG; Bigio, IJ; Lovat, LB; Bloom, SL; (2006) Elastic scattering spectroscopy for the diagnosis of colonic lesions: initial results of a novel optical biopsy technique. GASTROINTEST ENDOSC , 63 (2) 257 - 261. 10.1016/j.gie.2005.07.026.

Direkze, S.G.; (2006) Characterisation of transcriptional mediator subunit, MED17 and its regulation by cyclins. Doctoral thesis, University of London. Green open access

Duarte, RF; Pamphilon, D; Cornish, J; Shaw, BE; Samson, D; Craddock, C; Marks, D; (2006) Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London - 2005. BONE MARROW TRANSPL , 37 (10) 901 - 908. 10.1038/sj.bmt.1705365.

Dzwonek, A; Clapson, M; Withey, S; Bates, A; Novelli, V; (2006) Severe gynecomastia in an African boy with perinatally acquired human immunodeficiency virus infection receiving highly active antiretroviral therapy. The Pediatric Infectious Disease Journal , 25 (2) pp. 183-184.

de Bakker, PIW; McVean, G; Sabeti, PC; Miretti, MM; Green, T; Marchini, J; Ke, XY; (2006) A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. NAT GENET , 38 (10) 1166 - 1172. 10.1038/ng1885.

de Bruin, EC; van de Velde, CJ; van de Pas, S; Nagtegaal, ID; van Krieken, JH; Gosens, MJ; Peltenburg, LT; (2006) Prognostic value of apoptosis in rectal cancer patients of the dutch total mesorectal excision trial: radiotherapy is redundant in intrinsically high-apoptotic tumors. Clin Cancer Res , 12 (21) pp. 6432-6436. 10.1158/1078-0432.CCR-06-0231.

de Laat, B; Derksen, RHWM; Mackie, IJ; Roest, M; Schoormans, S; Woodhams, BJ; de Groot, PG; (2006) Annexin A5 polymorphism (-1C -> T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. ANN RHEUM DIS , 65 (11) 1468 - 1472. 10.1136/ard.2005.045237.


Eckhardt, F; Lewin, J; Cortese, R; Rakyan, VK; Attwood, J; Burger, M; Burton, J; (2006) DNA methylation profiling of human chromosomes 6, 20 and 22. NAT GENET , 38 (12) 1378 - 1385. 10.1038/ng1909.

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; (2006) Targeting the tumour vasculature: therapeutic efficacy of a 131I-labeled antibody against the ED-B domain of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings. (pp. 63-).

El, EE; Dearling, J; Huhalov, A; Robson, P; Neri, D; van, DGA; Zardi, L; (2006) Targeting tumour vasculature in human colorectal xenografts using an antibody against the extra-domain B of fibronectin. BACR/BMS Tumour vasculature: New targets and Therapies. In: (pp. 18-).


Filipe-Santos, O; Bustamante, J; Chapgier, A; Vogt, G; de Beaucoudrey, L; Feinberg, J; Jouanguy, E; (2006) Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol , 18 (6) pp. 347-361. 10.1016/j.smim.2006.07.010.

Filipe-Santos, O; Bustamante, J; Haverkamp, MH; Vinolo, E; Ku, CL; Puel, A; Frucht, DM; (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med , 203 (7) pp. 1745-1759. 10.1084/jem.20060085.

Finnegan, DPJ; Kettle, P; Drake, M; Matthews, C; Alexander, HD; Popat, R; Cavanagh, JD; (2006) Bortezomib is effective in primary plasma cell leukemia. LEUKEMIA & LYMPHOMA , 47 (8) pp. 1670-1673. 10.1080/10428190500520954.

Flanagan, J; Popendikyte, V; Pozdniakovaite, N; Sobolev, M; Assadzadeh, A; Schumacher, A; Zangeneh, M; (2006) Intra- and Inter- Individual Epigenetic Variation in Human Germ Cells. The American Journal of Human Genetics , 79 (1) pp. 67-84.

Fletcher, JM; Ferrier, PM; Gardner, JO; Harkness, L; Dhanjal, S; Serhal, P; Harper, J; (2006) Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines. CLONING STEM CELLS , 8 (4) 319 - 334.

Flores, L; Staples, A; Mackay, H; Howard, C; Uthe, P; Sexton, J; Buchmueller, K; (2006) Synthesis and evaluation of LVF-I-141: An intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY , 231 ? - ?.

Flores, LV; Staples, AM; Mackay, H; Howard, CM; Uthe, PB; Sexton, JS; Buchmueller, KL; (2006) Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase II alpha promoter. CHEMBIOCHEM , 7 (11) 1722 - 1729. 10.1002/cbic.200600155.

Florijn, RJ; Loves, W; Wenniger-Prick, LJJMMD; Mannens, MMAM; Tijmes, N; Brooks, SP; Hardcastle, AJ; (2006) New mutations in the NHS gene in Nance-Horan Syndrome families from the Netherlands. EUR J HUM GENET , 14 (9) 986 - 990. 10.1038/sj.ejhg.5201671.

Follows, GA; Dhami, P; Gottgens, B; Bruce, AW; Campbell, PJ; Dillon, SC; Smith, AM; (2006) Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites. GENOME RES , 16 (10) 1310 - 1319. 10.1101/gr.5373606.

Foroni, L; Mitchell, W; Rai, L; Gerrard, G; Patel, B; Goldstone, A; (2006) Molecular monitoring of minimal residual disease in adult ALL, the UKALL12 trial experience. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 52). BLACKWELL PUBLISHING

Foukas, LC; Claret, M; Pearce, W; Okkenhaug, K; Meek, S; Peskett, E; Sancho, S; (2006) Critical role for the p110 alpha phosphoinositide-3-OH kinase in growth and metabolic regulation. NATURE , 441 (7091) pp. 366-370. 10.1038/nature04694.

Fox, J; Alabassi, A; Patkar, V; Rose, T; Black, E; (2006) An ontological approach to modelling tasks and goals. COMPUT BIOL MED , 36 (7-8) 837 - 856. 10.1016/j.compbiomed.2005.04.011.

Fox, J; Patkar, V; Thomson, R; (2006) Decision support for health care: the PROforma evidence base. Inform Prim Care , 14 (1) pp. 49-54.

Friedmann, BJ; Caplin, M; Savic, B; Shah, T; Lord, CJ; Ashworth, A; Hartley, JA; (2006) Interaction of the epidermal growth factor receptor and the DNA-dependent protein kinase pathway following gefitinib treatment. MOL CANCER THER , 5 (2) 209 - 218. 10.1158/1535-7163.MCT-05-0239.

Fukuuchi, A; Nagamura, Y; Yaguchi, H; Ohkura, N; Obara, T; Tsukada, T; (2006) A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1. Jpn J Clin Oncol , 36 (11) pp. 739-744. 10.1093/jjco/hyl089.


Garcia, CA; Robinson, J; Guethlein, LA; Vilches, C; Parham, P; Madrigal, JA; Marsh, SGE; (2006) Human Killer-cell Immunoglobulin-like Receptor (KIR) polymorphism. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1208-1232). IHWG Press: Seattle.

Garcia, CA; Robinson, J; Shilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2006) KIR gene characterisation of HLA homozygous cell lines. In Immunobiology of the Human MHC. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1203-1207). IHWG Press: Seattle.

Garcia, JF; Roncador, G; García, JF; Sánz, AI; Maestre, L; Lucas, E; Montes-Moreno, S; (2006) PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica , 91 (4) pp. 467-474.

Garcia-Ortiz, JE; Sandoval-Ramirez, L; Rangel-Villalobos, H; Maldonado-Torres, H; Cox, S; Garcia-Sepulveda, CA; Figuera, LE; (2006) High-resolution molecular characterization of the HLA class I and class II in the Tarahumara Amerindian population. TISSUE ANTIGENS , 68 (2) pp. 135-146. 10.1111/j.1399-0039.2006.00636.x.

Garden, OJ; Rees, M; Poston, GJ; Mirza, D; Saunders, M; Ledermann, J; Primrose, JN; (2006) Guidelines for resection of colorectal cancer liver metastases. GUT , 55 (ARTN iii) pp. 1-8. 10.1136/gut.2006.098053.

Gardiner, C; Cohen, H; Austin, SK; Machin, SJ; Mackie, IJ; (2006) Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C. J THROMB HAEMOST , 4 (12) 2724 - 2726.

Gardiner, C; Cohen, H; Jenkins, A; Machin, SJ; Mackie, IJ; (2006) Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay. BLOOD COAGUL FIBRIN , 17 (6) 477 - 483.

Gardiner, C; Williams, K; Longair, I; Mackie, IJ; Machin, SJ; Cohen, H; (2006) A randomised control trial of patient self-management of oral anticoagulation compared with patient self-testing. BRIT J HAEMATOL , 132 (5) 598 - 603. 10.1111/j.1365-2141.2005.05899.x.

Gardiner, C; Williams, K; Mackie, IJ; Machin, SJ; Cohen, H; (2006) Can oral anticoagulation be managed using telemedicine and patient self-testing? A pilot study. CLIN LAB HAEMATOL , 28 (2) 122 - 125.

Gerrard, G; Mitchell, W; Patel, B; Goldstone, A; Fielding, A; Foroni, L; (2006) Minimal residual disease monitoring of BCR-ABL(+) adult acute lymphoblastic leukaemia using quantitative real-time PCR: preliminary results from the UKALLXII trial. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. pp. 53-54). BLACKWELL PUBLISHING

Gomez, K; McVey, JH; (2006) Tissue factor initiated blood coagulation. Frontiers in Bioscience , 11 pp. 1349-1359.

Grandage, VL; Everington, T; Linch, DC; Khwaja, A; (2006) Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells. BRIT J HAEMATOL , 135 (3) 303 - 316. 10.1111/j.1365-2141.2006.06291.x.

Grasso, A; Stigliano, R; Morisco, F; Martines, H; Quaglia, A; Dhillon, AP; Patch, D; (2006) Liver transplantation and recurrent hepatocellular carcinoma: Predictive value of nodule size in a retrospective and explant study. TRANSPLANTATION , 81 (11) 1532 - 1541. 10.1097/01.tp.0000209641.88912.15.

Greaves, LC; Preston, SL; Tadrous, PJ; Taylor, RW; Barron, MJ; Oukrif, D; Leedham, SJ; (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. Proceedings of the National Academy of Sciences of the United States of America , 103 (3) pp. 714-719. 10.1073/pnas.0505903103.

Greaves, LC; Preston, SL; Tadrous, PJ; Taylor, RW; Barron, MJ; Oukrif, D; Leedham, SJ; (2006) Mitochondrial DNA mutations are established in human colonic stem cells, and mutated clones expand by crypt fission. P NATL ACAD SCI USA , 103 (3) 714 - 719. 10.1073/pnas.0505903103.

Gregory, SG; Barlow, KF; McLay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; (2006) The DNA sequence and biological annotation of human chromosome 1. Nature , 441 (7091) pp. 315-321. 10.1038/nature04727.

Gregory, SG; Barlow, KF; Mclay, KE; Kaul, R; Swarbreck, D; Dunham, A; Scott, CE; (2006) The DNA sequence and biological annotation of human chromosome 1. NATURE , 441 (7091) 315 - 321. 10.1038/nature04727.

Gross, DA; Chappert, P; Leboeuf, M; Monteilhet, V; Van Wittenberghe, L; Danos, O; Davoust, J; (2006) Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products. Blood , 108 (6) pp. 1841-1848. 10.1182/blood-2006-02-011981.

Gupta, A; Saifuddin, A; Briggs, TWR; Flanagan, AM; (2006) Subperiosteal hemangioendothelioma of the femur. SKELETAL RADIOL , 35 (10) 793 - 796. 10.1007/s00256-005-0060-6.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; (2006) KIR gene in ethnic and Mestizo populations from Mexico. Human Immunology , 68 pp. 135-146.

Gutierrez-Rodriguez, ME; Sandoval-Ramirez, L; Diaz-Flores, M; Marsh, SGE; Valladares-Salgado, A; Madrigal, JA; Mejia-Arangure, JM; (2006) KIR gene in ethnic and mestizo populations from Mexico. HUMAN IMMUNOLOGY , 67 (1-2) pp. 85-93. 10.1016/j.humimm.2005.11.007.


Harish, S; Hughes, RJ; Saifuddin, A; Flanagan, AM; (2006) Image-guided percutaneous biopsy of intramedullary lytic bone lesions: utility of aspirated blood clots. EUR RADIOL , 16 (9) 2120 - 2125. 10.1007/s00330-005-0127-8.

Harrison, ML; Hoskins, P; du Bois, A; Quinn, M; Rustin, GJS; Ledermann, JA; Baron-Hay, S; (2006) Small cell of the ovary, hypercalcemic type - Analysis of combined experience and recommendation for management. A GCIG study. GYNECOL ONCOL , 100 (2) 233 - 238. 10.1016/j.ygyno.2005.10.024.

Hergovich, A; Lisztwan, J; Thoma, CR; Wirbelauer, C; Barry, RE; Krek, W; (2006) Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. MOL CELL BIOL , 26 (15) 5784 - 5796. 10.1128/MCB.00232-06.

Hergovich, A; Schmitz, D; Hemmings, BA; (2006) The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. BIOCHEM BIOPH RES CO , 345 (1) 50 - 58. 10.1016/j.bbrc.2006.03.244.

Hergovich, A; Stegert, MR; Schmitz, D; Hemmings, BA; (2006) NDR kinases regulate essential cell processes from yeast to humans. NAT REV MOL CELL BIO , 7 (4) 253 - 264. 10.1038/nrm1891.

Hollak, CEM; Hughes, D; Schwierin, B; Bembi, B; (2006) IS3: An approach to safety monitoring in daily practice. J INHERIT METAB DIS , 29 42 - 42.

Horton, R; Coggill, P; Miretti, MM; Sambrook, JG; Traherne, JA; Ward, R; Sims, S; (2006) The LRC haplotype project: a resource for killer immunoglobulin-like receptor-linked association studies. TISSUE ANTIGENS , 68 (5) 450 - 452. 10.1111/j.1399-0039.2006.00697.x.

Howard, J; Brazma, D; Vaughan, B; Nacheva, EP; (2006) Bi-allelic involvement in AML: Examples of 16q aberrations in two cases. In: BLOOD. (pp. 193B - 193B). AMER SOC HEMATOLOGY

Howard, J; Brazma, D; Vaughan, BR; Nacheva, EP; (2006) Polysomy 8 in CML. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 65 - 65). BLACKWELL PUBLISHING

Hughes, DA; (2006) The use of scoring systems in patients with haematological malignancy. ACTA PAEDIATRICA , 95 47 - 51. 10.1080/08035320600618866.

Hughes, DA; Reed, M; Baker, RJ; Richfield, L; Milligan, A; Evans, S; Blincoe, M; (2006) Enhanced differentiation of osteoclasts from mononuclear precursors in patients with Gaucher disease. J INHERIT METAB DIS , 29 21 - 21.


Ings, SJ; Balsa, C; Leverett, D; Mackinnon, S; Linch, DC; Watts, MJ; (2006) Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. BRIT J HAEMATOL , 134 (5) 517 - 525. 10.1111/j.1365-2141.2006.06223.x.


Jacobs, IJ; Mackay, J; Menon, U; Skates, SJ; Rosenthal, AN; Fraser, L; (2006) Familial ovarian screening--effective or ineffective? British Journal of Cancer , 23 (9) pp. 1126-1127.

Jell, G; Kerjaschki, D; Revell, P; Al-Saffar, N; (2006) Lymphangiogenesis in the bone-implant interface of orthopedic implants: importance and consequence. J BIOMED MATER RES A , 77A (1) 119 - 127. 10.1002/jbm.a.30548.

Jellinek, DA; Levy, D; Maltby, E; Atkey, N; Hibberd, S; Crimmins, D; Stoeber, K; (2006) Cytogenetic subtypes of oligodendroglioma differ in their apoptotic index, while the population of replication-licensed, non-proliferating cells is higher in anaplastic tumors but does not differ according to 1p,19q status. In: NEURO-ONCOLOGY. (pp. 459 - 459). DUKE UNIV PRESS

Jenkins, V; Shilling, V; Deutsch, G; Bloomfield, D; Morris, R; Allan, S; Bishop, H; (2006) A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer , 94 (6) pp. 828-834. 10.1038/sj.bjc.6603029.

Jennings, BH; Pickles, LM; Wainwright, SM; Roe, SM; Pearl, LH; Ish-Horowicz, D; (2006) Molecular recognition of transcriptional repressor motifs by the WD domain of the Groucho/TLE corepressor. Mol Cell , 22 (5) pp. 645-655. 10.1016/j.molcel.2006.04.024.

Jones, RL; Swanton, C; Ewer, MS; (2006) Anthracycline cardiotoxicity. Expert Opin Drug Saf , 5 (6) pp. 791-809. 10.1517/14740338.5.6.791.


Kakourou, G; Dhanjal, S; Sud, R; Mamas, T; Doshi, A; Nuttall, S; Gotts, S; (2006) Preimplantation genetic diagnosis for non-syndrornic deafness. In: JOURNAL OF MEDICAL GENETICS. (pp. S58 - S58). B M J PUBLISHING GROUP

Kalve, I; Devitt, D; Little, AM; Liu, X; Tilanus, M; Marsh, SGE; Madrigal, JA; (2006) Evaluation of RSCA® as a novel, emerging HLA typing method. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 295-303). IHWG Press: Seattle.

Kang, S; Denley, A; Vanhaesebroeck, B; Vogt, PK; (2006) Oncogenic transformation induced by the p110 beta, -gamma, and -delta isoforms of class I phosphoinositide 3-kinase. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 103 (5) pp. 1289-1294. 10.1073/pnas.0510772103.

Karavolos, S; Caplin, M; Benjamin, E; Crow, J; Mould, T; (2006) Primary mucinous carcinoid tumour of the ovary: a case report. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , 27 (6) pp. 618-620.

Khan, K; Stubbs, M; Shah, T; Savage, K; Dhillon, AP; Caplin, ME; (2006) Gastrin and CCK2 processing in neuroendocrine tumours and cell lines: Therapeutic targets. In: GUT. (pp. A9 - A10). B M J PUBLISHING GROUP

Khanduri, S; Gerrard, G; Barton, R; Mulvenna, P; Lee, SM; (2006) Clinical trials assessing the optimal management of brain metastases - The state of play. CLINICAL ONCOLOGY , 18 (10) pp. 744-746. 10.1016/j.clon.2006.08.009.

Khwaja, A; (2006) The role of Janus kinases in haemopoiesis and haematological malignancy. BRIT J HAEMATOL , 134 (4) 366 - 384. 10.1111/j.1365-2141.2006.06206.x.

Klupsch, K; Downward, J; (2006) The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. CELL DEATH DIFFER , 13 (12) 2157 - 2159. 10.1038/sj.cdd.4401955.

Kluza, J; Mazinghien, R; Irwin, H; Hartley, JA; Bailly, C; (2006) Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. ANTI-CANCER DRUG , 17 (2) 155 - 164.

Kocjan, G; Feichter, G; Hagmar, B; Kapila, K; Kardum-Skelin, I; Kloboves, V; Kobayashi, TK; (2006) Fine needle aspiration cytology: a survey of current European practice. CYTOPATHOLOGY , 17 (5) 219 - 226.

Kogelberg, H; Sharma, SK; Qureshi, U; Tolner, B; Lowdell, M; Shabakhti, H; Robson, M; (2006) Clearance mechanism of a mannoseylated antibody enzyme fusion protein used in experimental cancer therapy. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 65-).

Korman, AJ; Peggs, KS; Allison, JP; (2006) Checkpoint blockade in cancer immunotherapy. ADV IMMUNOL , 90 297 - 339. 10.1016/S0065-2776(06)90008-X.

Koukourakis, M.I.; Bentzen, S.M.; Giatromanolaki, A.; Wilson, G.D.; Daley, F.M.; Saunders, M.I.; Dische, S.; (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Journal of Clinical Oncology , 24 (5) pp. 727-735. 10.1200/jco.2005.02.7474.

Koukourakis, MI; Bentzen, SM; Giatromanolaki, A; Wilson, GD; Daley, FM; Saunders, MI; Dische, S; (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol , 24 (5) pp. 727-735. 10.1200/JCO.2005.02.7474.

Kyriakou, C; Davies, M; Chatterjee, R; Castleton, A; Roberts, K; Peniket, A; Mackinnon, S; (2006) Female gonadal function following reduced intensity conditioning (RIC) allogeneic bone marrow transplantation for haematological malignancies. In: BLOOD. (pp. 962A - 963A). AMER SOC HEMATOLOGY

Kyriakou, C; Rabin, N; Nathwani, A; Pizzey, A; Linch, DC; Yong, K; (2006) Factors influencing short term in vivo biodistribution of human bone marrow derived mesenchymal stem cells (hMSCs) in a xenogeneic animal model. In: BLOOD. (pp. 908A - 908A). AMER SOC HEMATOLOGY

Kyriakou, CA; Yong, KL; Benjamin, R; Pizzey, A; Dogan, A; Singh, N; Davidoff, AM; (2006) Human mesenchymal stem cells (hMSCs) expressing truncated soluble vascular endothelial growth factor receptor (tsFlk-1) following lentiviral-mediated gene transfer inhibit growth of Burkitt's lymphoma in a murine model. J GENE MED , 8 (3) 253 - 264. 10.1002/jgm.840.


Lagging, M; Romero, AI; Westin, J; Norkrans, G; Dhillon, AP; Pawlotsky, JM; Zeuzem, S; (2006) IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection. HEPATOLOGY , 44 (6) 1617 - 1625. 10.1002/hep.21407.

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. UNSPECIFIED

Lai, CSL; Boshoff, C; Falzon, M; Lee, SM; (2006) Complete response to erlotinib treatment in brain metastases from recurrent NSCLC. THORAX , 61 (1) 91 - 91. 10.1136/thx.2005.052233.

Lambros, MB; Simpson, PT; Jones, C; Natrajan, R; Westbury, C; Steele, D; Savage, K; (2006) Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridization. Lab Invest , 86 (4) pp. 398-408. 10.1038/labinvest.3700390.

Laun, K; Coggill, P; Palmer, S; Sims, S; Ning, ZM; Ragoussis, J; Volpi, E; (2006) The leukocyte receptor complex in chicken is characterized by massive expansion and diversification of immunoglobulin-like loci. PLoS Genetics , 2 (5) , Article e73. 10.1371/journal.pgen.0020073. Green open access

Laurent, C; Quaglia, A; Foroni, L; Bioulac-Sage, P; Balabaud, C; Dhillon, AP; (2006) Genomic alteration is not associated with fatty and clear cell change in hepatocellular carcinomas and its precursor nodular lesions in cirrhotic liver. HEPATOL RES , 36 (1) 40 - 47. 10.1016/j.hepres.2006.06.003.

Lawrie, AS; Cardigan, R; Williamson, LW; Machin, SJ; Mackie, IJ; (2006) Fresh-frozen plasma (FFP) quality assessed by dynamics of the clotting process. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 118 - 119). BLACKWELL PUBLISHING

Lawrie, CH; Marafioti, T; Hatton, CS; Dirnhofer, S; Roncador, G; Went, P; Tzankov, A; (2006) Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling. Int J Cancer , 118 (12) pp. 3161-3166. 10.1002/ijc.21762.

Le, NM; Sielaff, AM; Cooper, AJ; Mackay, H; Brown, T; Kotecha, M; O'Hare, C; (2006) Binding of f-PIP, a pyrrole- and imidazole-containing triamide to the inverted CCAAT box-2 of the topoisomerase II alpha promoter and modulation of gene expression in cells. BIOORG MED CHEM LETT , 16 (24) 6161 - 6164. 10.1016/j.bmcl.2006.09.043.

Le Sann, C; Baron, A; Mann, J; van den Berg, H; Gunaratnam, M; Neidle, S; (2006) New mustard-linked 2-aryl-bis-benzimidazoles with anti-proliferative activity. Org Biomol Chem , 4 (7) pp. 1305-1312. 10.1039/b600567e.

Lee, TI; Jenner, RG; Boyer, LA; Guenther, MG; Levine, SS; Kumar, RM; Chevalier, B; (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell , 125 (2) pp. 301-313. 10.1016/j.cell.2006.02.043.

Lehmann, DJ; Barnardo, MCNM; Fuggle, S; Quiroga, I; Sutherland, A; Warden, DR; Barnetson, L; (2006) Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity? J NEUROINFLAMM , 3 , Article 33. 10.1186/1742-2094-3-33. Green open access

Lieb, JD; Beck, S; Bulyk, ML; Farnham, P; Hattori, N; Henikoff, S; Liu, XS; (2006) Applying whole-genome studies of epigenetic regulation to study human disease. CYTOGENET GENOME RES , 114 (1) 1 - 15. 10.1159/000091922.

Liso, A; Capello, D; Marafioti, T; Tiacci, E; Cerri, M; Distler, V; Paulli, M; (2006) Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. Blood , 108 (3) pp. 1013-1020. 10.1182/blood-2005-10-3949.

Lopez, M; Aguilera, R; Perez, C; Mendoza-Naranjo, A; Pereda, C; Ramirez, M; Ferrada, C; (2006) The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines. IMMUNOBIOLOGY , 211 (1-2) 127 - 136. 10.1016/j.imbio.2005.11.003.

Lovat, LB; Johnson, K; Mackenzie, GD; Clark, BR; Novelli, MR; Davies, S; O'Donovan, M; (2006) Elastic scattering spectroscopy accurately detects high grade dysplasia and cancer in Barrett's oesophagus. Gut , 55 (8) pp. 1078-1083. 10.1136/gut.2005.081497. Gold open access


Maharaj, L; Popat, R; Chahwan, A; Lister, AT; Cavenagh, JD; Middleton, B; Rioja, A; (2006) The novel HDAC inhibitor UCL67022 is highly potent in multiple myeloma and non-Hodgkin's lymphoma and is enhanced by bortezomib. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 735A-735A). AMER SOC HEMATOLOGY

Mansour, MR; (2006) A role for aberrant Notch signaling in acute myeloid leukemia? LEUKEMIA & LYMPHOMA , 47 (11) pp. 2280-2281. 10.1080/10428190600908109.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. LEUKEMIA , 20 (3) 537 - 539. 10.1038/sj.leu.2404101.

Mansour, MR; Linch, DC; Foroni, L; Goldstone, AH; Gale, RE; (2006) High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia [12]. Leukemia , 20 (3) pp. 537-539. 10.1038/sj.leu.2404101.

Mantovani, J; Holic, N; Martinez, K; Danos, O; Perea, J; (2006) A high throughput method for genome-wide analysis of retroviral integration. Nucleic Acids Res , 34 (19) , Article e134. 10.1093/nar/gkl716.

Marelli, L; Stigliano, R; Triantos, C; Senzolo, M; Cholongitas, E; Davies, N; Yu, D; (2006) Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev , 32 (8) pp. 594-606. 10.1016/j.ctrv.2006.08.002.

Marks, DJB; Harbord, MWN; MacAllister, R; Rahman, FZ; Young, J; Al-Lazikani, B; Lees, W; (2006) Defective acute inflammation in Crohn's disease: a clinical investigation. LANCET , 367 (9511) 668 - 678.

Markusen, JF; Mason, C; Hull, DA; Town, MA; Tabor, AB; Clements, M; Boshoff, CH; (2006) Behavior of adult human mesenchymal stem cells entrapped in alginate-GRGDY beads. TISSUE ENG , 12 (4) 821 - 830.

Marquis, J; Paillard, L; Audic, Y; Cosson, B; Danos, O; Le Bec, C; Osborne, HB; (2006) CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding. Biochem J , 400 (2) pp. 291-301. 10.1042/BJ20060490.

Marsh, SG; (2006) Nomenclature for factors of the HLA system, October 2005 update*. Int J Immunogenet , 33 (1) pp. 63-64. 10.1111/j.1744-313X.2006.00566.x.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2006) Nomenclature for factors of the HLA system, update September 2006. Tissue Antigens , 68 (6) pp. 540-542. 10.1111/j.1399-0039.2006.00713.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update April 2006. TISSUE ANTIGENS , 68 (3) pp. 270-272. 10.1111/j.1399-0039.2006.00655.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update August 2006. TISSUE ANTIGENS , 68 (6) pp. 537-539. 10.1111/j.1399-0039.2006.00711.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. TISSUE ANTIGENS , 67 (3) pp. 262-264. 10.1111/j.1399-0039.2006.00564.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update December 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 147-149. 10.1111/j.1744-313X.2006.00576.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update February 2006. TISSUE ANTIGENS , 67 (5) pp. 440-442. 10.1111/j.1399-0039.2006.00601.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update January 2006. TISSUE ANTIGENS , 67 (5) pp. 438-439. 10.1111/j.1399-0039.2006.00597.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update July 2006. TISSUE ANTIGENS , 68 (6) pp. 535-536. 10.1111/j.1399-0039.2006.00709.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update June 2006. TISSUE ANTIGENS , 68 (3) pp. 276-277. 10.1111/j.1399-0039.2006.00659.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update March 2006. TISSUE ANTIGENS , 68 (1) pp. 100-102. 10.1111/j.1399-0039.2006.00617.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update May 2006. TISSUE ANTIGENS , 68 (3) pp. 273-275. 10.1111/j.1399-0039.2006.00660.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. TISSUE ANTIGENS , 67 (3) pp. 260-261. 10.1111/j.1399-0039.2006.00561.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update November 2005. INTERNATIONAL JOURNAL OF IMMUNOGENETICS , 33 (2) pp. 145-146. 10.1111/j.1744-313X.2006.00575.x.

Marsh, SGE; (2006) Nomenclature for factors of the HLA system, update October 2005. TISSUE ANTIGENS , 67 (3) pp. 258-259. 10.1111/j.1399-0039.2005.00545.x.

Masir, N; Marafioti, T; Jones, M; Natkunam, Y; Rüdiger, T; Hansmann, ML; Mason, DY; (2006) Loss of CD19 expression in B-cell neoplasms. Histopathology , 48 (3) pp. 239-246. 10.1111/j.1365-2559.2005.02317.x.

Mason, AJ; Martinez, A; Glaubitz, C; Danos, O; Kichler, A; Bechinger, B; (2006) The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes. FASEB J , 20 (2) pp. 320-322. 10.1096/fj.05-4293fje.

Masterson, LA; Spanswick, VJ; Hartley, JA; Begent, RH; Howard, PW; Thurston, DE; (2006) Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy. BIOORG MED CHEM LETT , 16 (2) 252 - 256. 10.1016/j.bmcl.2005.10.017.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; (2006) A Phase I Study of Single Administration of Antibody-Directed Enzyme Prodrug Therapy with the Recombinant Anti-Carcinoembryonic Antigen Antibody-Enzyme Fusion Protein MFECP1 and a Bis-Iodo Phenol Mustard Prodrug. Clinical Cancer Research , 12 (21) pp. 6509-6516.

Mayer, A; Francis, RJ; Sharma, SK; Tolner, B; Springer, CJ; Martin, J; Boxer, GM; (2006) A phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti-carcinoembryonic antigen antibody-enzyme fusion protein MFECP1 and a bis-iodo phenol mustard prodrug. CLIN CANCER RES , 12 (21) 6509 - 6516. 10.1158/1078-0432.CCR-06-0769.

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. RADIOLOGY , 240 (1) 73 - 81. 10.1148/radiol.2401050709.

McCarville, MB; Streck, CJ; Dickson, PV; Li, CS; Nathwani, AC; Davidoff, AM; (2006) Angiogenesis inhibitors in a murine neuroblastoma model: Quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology , 240 (1) pp. 73-81. 10.1148/radiol.2401050709.

McGurk, CJ; Cummings, M; Koberle, B; Hartley, JA; Oliver, RT; Masters, JR; (2006) Regulation of DNA repair gene expression in human cancer cell lines. J CELL BIOCHEM , 97 (5) 1121 - 1136. 10.1002/jcb.20711.

McTiernan, A; Driver, D; Michelagnoli, MP; Kilby, AM; Whelan, JS; (2006) High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours. ANN ONCOL , 17 (8) 1301 - 1305. 10.1093/annonc/mdl108.

McTiernan, A; Meyer, T; Michelagnoli, MP; Lewis, I; Whelan, JS; (2006) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. PEDIATR BLOOD CANCER , 46 (3) 345 - 350. 10.1002/pbc.20562.

Middleton, D; Meenagh, A; Marsh, SGE; Martin, J; (2006) A HLA-Cw*03 allele, Cw*0322Q with limited or no expression. TISSUE ANTIGENS , 67 (4) pp. 343-345. 10.1111/j.1399-0039.2006.00571.x.

Middleton, M.R.; Ranson, M.; Lee, S.M.; Bridgewater, J.A.; (2006) Phase I study of 4-bromothenylguanine (4-BTG, PaTrin 2), an alkyltransferase inactivator and temozolomide. Clinical Cancer Research , 6 (Suppl.) 538a.

Miretti, MM; Beck, S; (2006) Immunogenomics: molecular hide and seek. Hum Genomics , 2 (4) pp. 244-251.

Miro, F; Nobile, C; Blanchard, N; Lind, M; Filipe-Santos, O; Fieschi, C; Chapgier, A; (2006) T cell-dependent activation of dendritic cells requires IL-12 and IFN-gamma signaling in T cells. J Immunol , 177 (6) pp. 3625-3634.

Montaner, D; Tarraga, J; Huerta-Cepas, J; Burguet, J; Vaquerizas, JM; Conde, L; Minguez, P; (2006) Next station in microarray data analysis: GEPAS. NUCLEIC ACIDS RESEARCH , 34 W486-W491. 10.1093/nar/gkl197. Gold open access

Moore, MJ; Schultes, CM; Cuesta, J; Cuenca, F; Gunaratnam, M; Tanious, FA; Wilson, WD; (2006) Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation. J Med Chem , 49 (2) pp. 582-599. 10.1021/jm050555a.

Moorhouse, AD; Santos, AM; Gunaratnam, M; Moore, M; Neidle, S; Moses, JE; (2006) Stabilization of G-quadruplex DNA by highly selective ligands via click chemistry. J Am Chem Soc , 128 (50) pp. 15972-15973. 10.1021/ja0661919.

Morsi, H; Yong, KL; Jewell, AP; (2006) Preferential survival of acute lymphoblastic leukemia cells at 33 degrees C is associated with up-regulation of bcl-2. LEUKEMIA LYMPHOMA , 47 (6) 1117 - 1122. 10.1080/10428190500404498.

Mudie, N.Y.; Swerdlow, A.J.; Higgins, C.D.; Smith, P.; Qiao, Z.; Hancock, B.W.; Hoskin, P.J.; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: a British cohort study. Journal of Clinical Oncology , 24 (10) pp. 1568-1574. 10.1200/JCO.2005.04.2200.

Mudie, NY; Swerdlow, AJ; Higgins, CD; Smith, P; Qiao, ZK; Hancock, BW; Hoskin, PJ; (2006) Risk of second malignancy after non-Hodgkin's lymphoma: A British cohort study. J CLIN ONCOL , 24 (10) 1568 - 1574. 10.1200/JCO.2005.04.2200.

Murugaesu, N; Schmid, P; Dancey, G; Agarwal, R; Holden, L; McNeish, I; Savage, PM; (2006) Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J Clin Oncol , 24 (30) pp. 4862-4866. 10.1200/JCO.2006.06.2489.


Nacheva, EP; Brazma, D; Benson, R; Howard, J; Virgil, A; Grace, C; (2006) Imbalances of the 9q34 region downstream of ABL gene in CML are associated with blast crisis. In: BLOOD. (pp. 601A - 601A). AMER SOC HEMATOLOGY

Nacheva, EP; Brazma, D; Grace, C; (2006) Screening CML for genetic imbalances by array CGH. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). BLACKWELL PUBLISHING

Nathwani, AC; Gray, JT; Ng, CYC; Zhou, JF; Spence, Y; Waddington, SN; Tuddenham, EGD; (2006) Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. BLOOD , 107 (7) 2653 - 2661. 10.1182/blood-2005-10-4035. Gold open access

Neild, GH; Rodriguez-Justo, M; Wall, C; Connolly, JO; (2006) Hyper-IgG4 disease: report and characterisation of a new disease. BMC Medicine , 4 , Article 23. 10.1186/1741-7015-4-23. Green open access

Newton, R; Carpenter, L; Casabonne, D; Beral, V; Babiker, A; Darbyshire, J; Weller, I; (2006) A prospective study of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in adults with human immunodeficiency virus-1. BRIT J CANCER , 94 (10) 1504 - 1509. 10.1038/sj.bjc.6603100.

Nikitenko, L; Boshoff, C; (2006) Endothelial cells and cancer. Handb Exp Pharmacol (176 Pt 2) pp. 307-334.

Nikitenko, LL; Blucher, N; Fox, SB; Bicknel, R; Smith, DM; Rees, MCP; (2006) Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms. J CELL SCI , 119 (5) 910 - 922. 10.1242/jcs.02783.

Nikitenko, LL; Cross, T; Campo, L; Turley, H; Leek, R; Manek, S; Bicknell, R; (2006) Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: Endothelial phenotype and association with microvascular density. CLIN CANCER RES , 12 (19) 5648 - 5658. 10.1158/1078-0432.CCR-06-0852.

Nikitenko, LL; Fox, SB; Kehoe, S; Rees, MCP; Bicknell, R; (2006) Adrenomedullin and tumour angiogenesis. BRIT J CANCER , 94 (1) 1 - 7. 10.1038/sj.bjc.6602832.


O'Donnell, P; Diss, TC; Whelan, J; Flanagan, AM; (2006) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. SKELETAL RADIOL , 35 (4) 233 - 239. 10.1007/s00256-005-0006-z.

Okkenhaug, K; Patton, DT; Bilancio, A; Garcon, F; Rowan, WC; Vanhaesebroeck, B; (2006) The p110 delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells. JOURNAL OF IMMUNOLOGY , 177 (8) pp. 5122-5128.

Oliver, AW; Paul, A; Boxall, KJ; Barrie, SE; Aherne, GW; Garrett, MD; Mittnacht, S; (2006) Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange. EMBO J , 25 (13) pp. 3179-3190. 10.1038/sj.emboj.7601209.

Olivier, A; Jeanson-Leh, L; Bouma, G; Compagno, D; Blondeau, J; Seye, K; Charrier, S; (2006) A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells. MOL THER , 13 (4) 729 - 737. 10.1016/j.ymthe.2005.11.003.


Palmieri, C; Dhillon, T; Thirlwell, C; Newsom-Davis, T; Young, AM; Nelson, M; Gazzard, BG; (2006) Pulmonary Kaposi sarcoma in the era of highly active antiretroviral therapy. HIV MED , 7 (5) 291 - 293.

Pamphilon, D; Mackinnon, S; Nacheva, E; Russell, N; Wilson, K; Clay, M; Miller, J; (2006) The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors. Bone Marrow Transplant , 38 (10) pp. 699-700. 10.1038/sj.bmt.1705508.

Pankhurst, T; Howie, AJ; Adu, D; Wallace, DM; Lipkin, GW; (2006) Incidental neoplasms in renal biopsies. Nephrol Dial Transplant , 21 (1) pp. 64-69. 10.1093/ndt/gfi149.

Panner, A; Nakamura, JL; Parsa, AT; Rodriguez-Viciana, P; Berger, MS; Stokoe, D; Pieper, RO; (2006) MTOR-independent translational control of the extrinsic cell death pathway by RalA. MOL CELL BIOL , 26 (20) 7345 - 7357. 10.1128/MCB.00126-06.

Paston, S.J.; (2006) CMV epitope selection and its use in T cell reconstitution in patients undergoing haematopoietic stem cell transplantation. Doctoral thesis, University of London. Green open access

Paterson, JC; Tedoldi, S; Craxton, A; Jones, M; Hansmann, ML; Collins, G; Roberton, H; (2006) The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas. Haematologica , 91 (6) pp. 772-780.

Patkar, V; Hurt, C; Steele, R; Love, S; Purushotham, A; Williams, M; Thomson, R; (2006) Evidence-based guidelines and decision support services: a discussion and evaluation in triple assessment of suspected breast cancer. BRIT J CANCER , 95 (11) 1490 - 1496. 10.1038/sj.bjc.6603470.

Patton, DT; Garden, OA; Pearce, WP; Clough, LE; Monk, CR; Leung, E; Rowan, WC; (2006) Cutting edge: The phosphoinositide 3-kinase p110 delta is critical for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. JOURNAL OF IMMUNOLOGY , 177 (10) pp. 6598-6602.

Pawelec, G; Marsh, SG; (2006) ESTDAB: a collection of immunologically characterised melanoma cell lines and searchable databank. CANCER IMMUNOLOGY IMMUNOTHERAPY , 55 (6) pp. 623-627. 10.1007/s00262-005-0117-3.

Pedrazzoli, P; Ledermann, JA; Lotz, JP; Leyvraz, S; Aglietta, M; Rosti, G; Champion, KM; (2006) High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. ANN ONCOL , 17 (10) 1479 - 1488. 10.1093/annonc/mdl044.

Peggs, KS; (2006) Improving cellular therapies in Epstein-Barr virus-associated Hodgkin's lymphoma: shifting the equilibrium between effectors and regulators - Commentary on: Bollard et al. In vivo expansion of LMP 1-and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation. Leuk Lymphoma 2006; 47 : 837-842. LEUKEMIA LYMPHOMA , 47 (5) 787 - 789. 10.1080/10428190600648630.

Peggs, KS; (2006) Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans. CYTOTHERAPY , 8 (5) 427 - 436. 10.1080/14653240600851938.

Peggs, KS; Quezada, SA; Korman, AJ; Allison, JP; (2006) Principles and use of anti-CTLA4 antibody in human cancer immunotherapy. CURR OPIN IMMUNOL , 18 (2) 206 - 213. 10.1016/j.coi.2006.01.011.

Perumal, M; Pillai, RG; Barthel, H; Leyton, J; Latigo, JR; Forster, M; Mitchell, F; (2006) Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography. Cancer Res , 66 (17) pp. 8558-8564. 10.1158/0008-5472.CAN-06-0898.

Pfisterer, J; Ledermann, JA; (2006) Management of Platinum-Sensitive Recurrent Ovarian Cancer. Seminars in Oncology , 33 (SUPPL. 6) pp. 12-16. 10.1053/j.seminoncol.2006.03.012.

Pfisterer, J; Ledermann, JA; (2006) Management of platinum-sensitive recurrent ovarian cancer. SEMIN ONCOL , 33 (2) S12 - S16. 10.1053/j.seminoncol.2006.03.012.

Picard, C; Filipe-Santos, O; Chapgier, A; von Bernuth, H; Vogt, G; Casanova, JL; (2006) [Genetic predisposition and children infectious disease]. Arch Pediatr , 13 (10) pp. 1342-1346. 10.1016/j.arcped.2006.07.009.

Pillay, OC; Te Fong, LFW; Crow, JC; Benjamin, E; Mould, T; Atiomo, W; Menon, PA; (2006) The association between polycystic ovaries and endometrial cancer. HUM REPROD , 21 (4) 924 - 929. 10.1093/humrep/dei420.

Pinti, M; Salomoni, P; Cossarizza, A; (2006) Anti-HIV drugs and the mitochondria. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS , 1757 (5-6) 700 - 707. 10.1016/j.bbabio.2006.05.001.

Pollard, S; Conti, L; Smith, A; (2006) Exploitation of adherent neural stem cells in basic and applied neurobiology. Regen Med , 1 (1) pp. 111-118. 10.2217/17460751.1.1.111.

Pollard, SM; Benchoua, A; Lowell, S; (2006) Neural stem cells, neurons, and glia. Methods Enzymol , 418 pp. 151-169. 10.1016/S0076-6879(06)18010-6.

Pollard, SM; Conti, L; Sun, Y; Goffredo, D; Smith, A; (2006) Adherent neural stem (NS) cells from fetal and adult forebrain. Cereb Cortex , 16 Sup i112-i120. 10.1093/cercor/bhj167.

Pollard, SM; Parsons, MJ; Kamei, M; Kettleborough, RN; Thomas, KA; Pham, VN; Bae, MK; (2006) Essential and overlapping roles for laminin alpha chains in notochord and blood vessel formation. Dev Biol , 289 (1) pp. 64-76. 10.1016/j.ydbio.2005.10.006.

Popat, R; Goff, L; Oakervee, H; Cavenagh, JD; Joel, SP; (2006) Schedule dependent effect of bortezomib and melphalan for multiple myeloma associated with changes in Mcl-1 expression. In: (Proceedings) 46th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 99). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Joel, S; Oakervee, H; Cavenagh, J; (2006) Bortezomib for multiple myeloma. Expert Opin Pharmacother , 7 (10) pp. 1337-1346. 10.1517/14656566.7.10.1337.

Popat, R; Oakervee, H; Curry, N; Foot, N; Morris, C; Drake, M; Agrawal, S; (2006) Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma. In: (Proceedings) 46th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 99). WILEY-BLACKWELL PUBLISHING, INC

Popat, R; Oakervee, HE; Foot, N; Agrawal, S; Odeh, L; Craddock, C; Williams, C; (2006) Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma. In: (Proceedings) 46th Annual Scientific Meetign of the British-Society-for-Haematology. (pp. p. 98). BLACKWELL PUBLISHING

Popat, R; Williams, C; Cook, M; Craddock, C; Basu, S; Singer, C; Odeh, L; (2006) A phase I/II trial of bortezomib, low dose intravenous melphalan and dexamethasone for patients with relapsed multiple myeloma. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 1011A-1011A). AMER SOC HEMATOLOGY

Pors, K; Shnyder, SD; Teesdale-Spittle, PH; Hartley, JA; Zloh, M; Searcey, M; Patterson, LH; (2006) Synthesis of DNA-directed pyrrolidinyl and piperidinyl confined alkylating chloroalkylaminoanthraquinones: Potential for development of tumor-selective N-oxides. J MED CHEM , 49 (24) 7013 - 7023. 10.1021/jm0608154.

Porter, JB; (2006) Deferasirox: An effective once-daily orally active iron chelator. DRUG TODAY , 42 (10) 623 - 637. 10.1358/dot.2006.42.10.1009901.

Purnell, B; Lingerfelt, B; Scott, A; Townes, H; Summerville, K; Hudson, S; Kiakos, K; (2006) Novel (S)-(-)- and R-(+)-seco-iso-cyclopropylfurano[e]indoline-5,6,7-trimethoxyindole-2-carboxamide (iso-CFI) Analogs of Duocarmycin C2: Synthesis and Biological Evaluation. MEDICINAL CHEMISTRY , 2 (2) pp. 139-146. 10.2174/157340606776056188.

Purnell, B; Sato, A; O'Kelley, A; Price, C; Summerville, K; Hudson, S; O'Hare, C; (2006) DNA interstrand crosslinking agents: Synthesis, DNA interactions, and cytotoxicity of dimeric achiral seco-amino-CBI and conjugates of achiral seco-amino-CBI with pyrrolobenzodiazepine (PBD). BIOORG MED CHEM LETT , 16 (21) 5677 - 5681. 10.1016/j.bmcl.2006.08.005.


Quaglia, A; McStay, M; Stoeber, K; Loddo, M; Caplin, M; Fanshawe, T; Williams, G; (2006) Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma. LIVER INT , 26 (4) 424 - 432. 10.1111/j.1478-3231.2006.01242.x.

Quezada, SA; Peggs, KS; Curran, MA; Allison, JP; (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J CLIN INVEST , 116 (7) 1935 - 1945. 10.1172/JCI27745. Green open access


Rabin, N; Kyriakou, C; Benjamin, R; Pizzey, A; Gallagher, O; Singh, N; Buckle, C; (2006) Gene modified human mesenchymal stem cells expressing osteoprotegerin inhibit osteoclast activation and increase trabecular bone area in a xenogeneic murine model of myeloma. In: BLOOD. (pp. 153A - 153A). AMER SOC HEMATOLOGY

Rabin, N; Kyriakou, C; Pizzey, A; Buckle, C; Prideaux, M; Croucher, P; Nathwani, A; (2006) Gene Modified Human Mesenchymal Stem Cells Expressing Osteoprotegerin Reverse Osteoclast Activation in a Xenogeneic Murine Model of Multiple Myeloma. MOLECULAR THERAPY , 13 S256-S256.

Raeiszadeh, M; Kopycinski, J; Paston, SJ; Diss, T; Lowdell, M; Hardy, GAD; Hislop, AD; (2006) The T cell response to persistent herpes virus infections in common variable immunodeficiency. CLIN EXP IMMUNOL , 146 (2) 234 - 242. 10.1111/j.1365-2249.2006.03209.x.

Rakyan, VK; Beck, S; (2006) Epigenetic variation and inheritance in mammals. CURR OPIN GENET DEV , 16 (6) 573 - 577. 10.1016/j.gde.2006.09.002.

Ranson, M; Middleton, MR; Bridgewater, J; Lee, SM; Dawson, M; Jowle, D; Halbert, G; (2006) Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res , 12 (5) pp. 1577-1584. 10.1158/1078-0432.CCR-05-2198.

Ravn, P; Patel, A; Andre, M; Bicknell, R; Begent, R; Pedley, B; Chester, K; (2006) Generation of Antibodies to Magic Roundabout 4, Robo4 using Phage Display. In: (Proceedings) NCRI Cancer Conference Proceedings.

Rebholz, H; Panasyuk, G; Fenton, T; Nemazanyy, I; Valovka, T; Flajolet, M; Ronnstrand, L; (2006) Receptor association and tyrosine phosphorylation of S6 kinases. FEBS J , 273 (9) 2023 - 2036. 10.1111/j.1742-4658.2006.05219.x.

Reis-Filho, JS; Westbury, C; Pierga, JY; (2006) The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol , 59 (3) pp. 225-231. 10.1136/jcp.2005.028324.

Remiszewski, P; Roszkowska-Sliz, B; Winek, J; Chapgier, A; Feinberg, J; Langfort, R; Bestry, I; (2006) Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNgammaR1 deficiency. Respiration , 73 (3) pp. 375-378. 10.1159/000088682.

Renard, C; Hart, E; Sehra, H; Beasley, H; Coggill, P; Howe, K; HarroW, J; (2006) The genomic sequence and analysis of the swine major histocompatibility complex. GENOMICS , 88 (1) 96 - +. 10.1016/j.ygeno.2006.01.004.

Rivière, C; Danos, O; Douar, AM; (2006) Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice. Gene Ther , 13 (17) pp. 1300-1308. 10.1038/sj.gt.3302766.

Robinson, J; Waller, MJ; Fail, SC; Marsh, SGE; (2006) The IMGT/HLA and IPD databases. HUMAN MUTATION , 27 (12) pp. 1192-1199. 10.1002/humu.20406.

Rodriguez-Justo, M; Chan, G; McNicol, A-M; (2006) Simultaneous occurrence of adrenal cortical adenoma and ganglioneuroma. HISTOPATHOLOGY , 49 (2) pp. 206-208. 10.1111/j.1365-2559.2006.02384.x.

Rodriguez-Viciana, P; Collins, C; Fried, M; (2006) Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. P NATL ACAD SCI USA , 103 (51) 19290 - 19295. 10.1073/pnas.0609343103.

Rodriguez-Viciana, P; Collins, CH; Moule, MG; Fried, M; (2006) Chromosomal instability at a mutational hotspot in polyoma middle T-antigen affects its ability to activate the ARF-p53 tumor suppressor pathway. ONCOGENE , 25 (10) 1454 - 1462. 10.1038/sj.onc.1209197.

Rodriguez-Viciana, P; McCormick, F; (2006) Characterization of interactions between Ras family GTPases and their effectors. METHOD ENZYMOL , 407 187 - 194. 10.1016/S0076-6879(05)07016-3.

Rodriguez-Viciana, P; McCormick, F; (2006) Ras ubiquitination: Coupling spatial-sorting and signal transmission. CANCER CELL , 9 (4) 243 - 244. 10.1016/j.ccr.2006.03.025.

Rodriguez-Viciana, P; Oses-Prieto, J; Burlingame, A; Fried, M; McCormick, F; (2006) A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity. MOL CELL , 22 (2) 217 - 230. 10.1016/j.molcel.2006.03.027.

Rodriguez-Viciana, P; Tetsu, O; Tidyman, WE; Estep, AL; Conger, BA; Cruz, MS; McCormick, F; (2006) Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome. SCIENCE , 311 (5765) 1287 - 1290. 10.1126/science.1124642.

Romero, AI; Lagging, M; Westin, J; Dhillon, AP; Dustin, LB; Pawlotsky, JM; Neumann, AU; (2006) Interferon (IFN)-gamma-inducible protein-10: Association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection. JOURNAL OF INFECTIOUS DISEASES , 194 (7) 895 - 903.

Ronald, A; Happé, F; Bolton, P; Butcher, LM; Price, TS; Wheelwright, S; Baron-Cohen, S; (2006) Genetic heterogeneity between the three components of the autism spectrum: a twin study. J Am Acad Child Adolesc Psychiatry , 45 (6) pp. 691-699. 10.1097/01.chi.0000215325.13058.9d.

Roscioli, T; Cliffe, ST; Bloch, DB; Bell, CG; Mullan, G; Taylor, PJ; Sarris, M; (2006) Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet , 38 (6) pp. 620-622. 10.1038/ng1780.

Rossi, C; Angelucci, A; Costantin, L; Braschi, C; Mazzantini, M; Babbini, F; Fabbri, ME; (2006) Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. EUR J NEUROSCI , 24 (7) 1850 - 1856. 10.1111/j.1460-9568.2006.05059.x.

Rossi, M; Aqeilan, RI; Neale, M; Candi, E; Salomoni, P; Knight, RA; Croce, CM; (2006) The E3 ubiquitin ligase Itch controls the protein stability of p63. P NATL ACAD SCI USA , 103 (34) 12753 - 12758. 10.1073/pnas.0603449103.

Ruszniewski, P; Delle Fave, G; Cadiot, G; Komminoth, P; Chung, D; Kos-Kudla, B; Kianmanesh, R; (2006) Well-differentiated gastric tumors/carcinomas. NEUROENDOCRINOLOGY , 84 (3) 158 - 164. 10.1159/000098007.


Sainz-Pastor, N; Tolner, B; Huhalov, A; Kogelberg, H; Lee, YC; Zhu, DL; Begent, RHJ; (2006) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , 39 (1-3) 141 - 150. 10.1016/j.ijbiomac.2006.03.022.

Salomoni, P; Guernah, I; Pandolfi, PP; (2006) The PML-nuclear body associated protein Daxx regulates the cellular response to CD40. CELL DEATH DIFFER , 13 (4) 672 - 675. 10.1038/sj.cdd.4401820.

Salomoni, P; Khelifi, AF; (2006) Daxx: death or survival protein? TRENDS CELL BIOL , 16 (2) 97 - 104. 10.1016/j.tcb.2005.12.002.

Sambrook, JG; Bashirova, A; Andersen, H; Piatak, M; Vernikos, GS; Coggill, P; Lifson, JD; (2006) Identification of the ancestral killer immunoglobulin-like receptor gene in primates. BMC GENOMICS , 7 , Article 209. 10.1186/1471-2164-7-209. Green open access

Sambrook, JG; Sehra, H; Coggill, P; Humphray, S; Palmer, S; Sims, S; Takamatsu, HH; (2006) Identification of a single killer immunoglobulin-like receptor (KIR) gene in the porcine leukocyte receptor complex on chromosome 6q. IMMUNOGENETICS , 58 (5-6) 481 - 486. 10.1007/s00251-006-0110-9.

Samonakis, DN; Mela, M; Quaglia, A; Triantos, CK; Thalheimer, U; Leandro, G; Pesci, A; (2006) Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis. TRANSPL INFECT DIS , 8 (1) 3 - 12.

Savage, K; Waller, HA; Stubbs, M; Khan, K; Watson, SA; Clarke, PA; Grimes, S; (2006) Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines. INT J ONCOL , 29 (6) 1429 - 1435.

Schrag, A; Sampaio, C; Counsell, N; Poewe, W; (2006) Minimal clinically important change on the Unified Parkinson's Disease Rating Scale. MOVEMENT DISORD , 21 (8) 1200 - 1207. 10.1002/mds.20914.

Schreiber, J; Jenner, RG; Murray, HL; Gerber, GK; Gifford, DK; Young, RA; (2006) Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci U S A , 103 (15) pp. 5899-5904. 10.1073/pnas.0510996103.

Schumacher, A; Kapranov, P; Flanagan, J; Kaminsky, Z; Yao, P; Vitkute, J; Winegarden, N; (2006) Microarray-based large scale profiling of DNA methylation. Nucleic Acids Research , 34 (2) pp. 528-542. Gold open access

Schwarting, A; Dehout, F; Feriozzi, S; Beck, M; Mehta, A; Sunder-Plassmann, G; European FOS Investigators, ; (2006) Enzyme replacement therapy and renal function in 201 patients with Fabry disease. Clin Nephrol , 66 (2) pp. 77-84.

Scully, M; Starke, R; Lee, R; Mackie, I; Machin, S; Cohen, H; (2006) Successful management of pregnancy in women with a history of thrombotic thrombocytopaenic purpura. BLOOD COAGUL FIBRIN , 17 (6) 459 - 463.

Sekhon, R; Knock, J; Shah, M; Maude, K; Stoeber, K; Williams, G; Howdle, P; (2006) MCMs and geminin: Similar expression but different relationship to survival in small bowel compared to gastric cancer. In: JOURNAL OF PATHOLOGY. (pp. 11 - 11). JOHN WILEY & SONS LTD

Senzolo, M; Patch, D; Cholongitas, E; Triantos, C; Marelli, L; Stigliano, R; Dhillon, AP; (2006) Severe venoocclusive disease after liver transplantation treated with transjugular intrahepatic portosystemic shunt. Transplantation , 82 pp. 132-135.

Shah, T; Hochhauser, D; Frow, R; Quaglia, A; Dhillon, AP; Caplin, ME; (2006) Epidermal growth factor receptor expression and activation in neuroendocrine tumours. J NEUROENDOCRINOL , 18 (5) 355 - 360. 10.1111/j.1365-2826.2006.01425.x.

Shaw, BE; Marsh, SGE; Madrigal, JA; (2006) Role of HLA matching in unrelated donor transplant – An update of the Anthony Nolan data. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 1392-1394). IHWG Press: Seattle.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. BLOOD , 107 (3) 1220 - 1226. 10.1182/blood-2005-08-3121.

Shaw, BE; Marsh, SGE; Mayor, NP; Russell, NH; Madrigal, JA; (2006) HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood , 107 (3) pp. 1220-1226. 10.1182/blood-2005-08-3121. Green open access

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Marsh, SGE; Madrigal, JA; (2006) Graft versus host disease in matched T cell depleted unrelated donor haematopoietic stem cell transplants. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 635-638). IHWG Press: Seattle.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, N; Pay, AL; Travers, P; Marsh, SGE; (2006) Disease relapse following volunteer donor haematopoietic stem cell transplantation. In: Hansen, JA, (ed.) (Proceedings) 13th International Histocompatibility Workshop and Conference. (pp. pp. 631-634). IHWG Press: Seattle.

Sieber, OM; Segditsas, S; Knudsen, AL; Zhang, J; Luz, J; Rowan, AJ; Spain, SL; (2006) Disease severity and genetic pathways in attenuated familial adenomatous polyposis vary greatly but depend on the site of the germline mutation. GUT , 55 (10) 1440 - 1448. 10.1136/gut.2005.087106.

Silva, E.; (2006) The role of tumour suppressor fat in the patterning and development of the Drosophila eye. Doctoral thesis, University of London. Green open access

Silva, J; Chambers, I; Pollard, S; Smith, A; (2006) Nanog promotes transfer of pluripotency after cell fusion. Nature , 441 (7096) pp. 997-1001. 10.1038/nature04914.

Slack, E.M.C.; (2006) Regulation of dendritic cell function by Dectin-1. Doctoral thesis, University of London. Green open access

Smith, A; Wisloff, F; Samson, D; (2006) Guidelines on the diagnosis and management of multiple myeloma 2005. BRITISH JOURNAL OF HAEMATOLOGY , 132 (4) pp. 410-451. 10.1111/j.1365-2141.2005.05867.x.

Soeiro, I; Mohamedali, A; Romanska, HM; Lea, NC; Child, ES; Glassford, J; Orr, SJ; (2006) p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol , 26 (16) pp. 6170-6184. 10.1128/MCB.02182-05.

Spender, LC; Lucchesi, W; Bodelon, G; Bilancio, A; Karstegl, CE; Asano, T; Dittrich-Breiholz, O; (2006) Cell target genes of Epstein-Barr virus transcription factor EBNA-2: induction of the p55 alpha regulatory subunit of PI3-kinase and its role in survival of EREB2.5 cells. JOURNAL OF GENERAL VIROLOGY , 87 pp. 2859-2867. 10.1099/vir.0.82128-0.

Spiro, S.G.; James, L.E.; Rudd, R.M.; Trask, C.W.; Tobias, J.S.; Snee, M.; Gilligan, D.; (2006) Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. Journal of Clinical Oncology , 24 (24) pp. 3823-3830. 10.1200/jco.2005.05.3181.

Spiro, SG; James, LE; Rudd, RM; Trask, CW; Tobias, JS; Snee, M; Gilligan, D; (2006) Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: A London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. JOURNAL OF CLINICAL ONCOLOGY , 24 (24) 3823 - 3830. 10.1200/JCO.2005.05.3181.

Standish, RA; Cholongitas, E; Dhillon, A; Burroughs, AK; Dhillon, AP; (2006) An appraisal of the histopathological assessment of liver fibrosis. GUT , 55 (4) 569 - 578. 10.1136/gut.2005.084475.

Starke, R; Mackie, I; Drummond, O; MacGregor, I; Harrison, P; Machin, S; (2006) Prion protein in patients with renal failure. TRANSFUSION MED , 16 (3) 165 - 168. 10.1111/j.1365-3148.2006.00662.x.

Stebbing, J; Mazhar, D; Palmieri, C; Thirlwell, C; Powles, T; Nelson, M; Gazzard, B; (2006) Non cutaneous AIDS-associated Kaposi's sarcoma. J Clin Oncol , 24 (18_suppl) 9555-.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; Lowdell, MW; (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. LEUKEMIA , 20 (6) 1073 - 1079. 10.1038/sj.leu.2404230.

Steele, AJ; Jones, DT; Ganeshaguru, K; Duke, VM; Yogashangary, BC; North, JM; Lowdell, MW; (2006) The sesquiterpene lactone parthenolide induces selective apoptosis of B-chronic lymphocytic leukemia cells in vitro. Leukemia , 20 (6) pp. 1073-1079. 10.1038/sj.leu.2404230.

Steele, AJ; Prentice, AG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; Wickremasinghe, RG; (2006) Generation of reactive oxygen species by parthenolide rapidly and selectively induces apoptosis of B-chronic lymphocytic leukaemia (CLL) cells via a p53 independent pathway. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 53 - 53). BLACKWELL PUBLISHING

Stewart, MH; Bosse, M; Chadwick, K; Menendez, P; Bendall, SC; Bhatia, M; (2006) Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. NATURE METHODS , 3 (10) pp. 807-815. 10.1038/nmeth939.

Stewart, WA; Bomanji, JB; Mackinnon, S; Kottaridis, PD; (2006) Diffuse bowel fluorodeoxyglucose uptake on positron emission tomography scan following allogeneic stem cell transplant. Br J Haematol , 133 (3) 219-. 10.1111/j.1365-2141.2006.06040.x.

Strauss, SJ; Maharaj, L; Hoare, S; Johnson, PW; Radford, JA; Vinnecombe, S; Millard, L; (2006) Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. J Clin Oncol , 24 (13) pp. 2105-2112. 10.1200/JCO.2005.04.6789.

Streck, CJ; Dickson, PV; Ng, CYC; Zhou, J; Hall, MM; Gray, JT; Nathwani, AC; (2006) Antitumor efficacy of AAV-mediated systemic delivery of interferon-β. Cancer Gene Therapy , 13 (1) pp. 99-106. 10.1038/sj.cgt.7700878.

Swanton, C; Futreal, A; Eisen, T; (2006) Her2-targeted therapies in non-small cell lung cancer. Clin Cancer Res , 12 (14 Pt 2) 4377s-4383s. 10.1158/1078-0432.CCR-06-0115.

Swanton, C; Tomlinson, I; Downward, J; (2006) Chromosomal instability, colorectal cancer and taxane resistance. Cell Cycle , 5 (8) pp. 818-823. 10.4161/cc.5.8.2682.

Syed, N; Smith, P; Sullivan, A; Spender, LC; Dyer, M; Karran, L; O'Nions, J; (2006) Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies. BLOOD , 107 (1) pp. 250-256. 10.1182/blood-2005-03-1194.


Takahashi, M; Kikuchi, M; Ohkura, N; Yaguchi, H; Nagamura, Y; Ohnami, S; Ushiama, M; (2006) Detection of APC gene deletion by double competitive polymerase chain reaction in patients with familial adenomatous polyposis. Int J Oncol , 29 (2) pp. 413-421.

Tedoldi, S; Paterson, JC; Cordell, J; Tan, SY; Jones, M; Manek, S; Dei Tos, AP; (2006) Jaw I/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. Journal of Pathology , 209 (4) pp. 454-463. 10.1002/path.2002.

Tedoldi, S; Paterson, JC; Cordell, J; Tan, SY; Jones, M; Manek, S; Dei Tos, AP; (2006) Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas. J Pathol , 209 (4) pp. 454-463. 10.1002/path.2002.

Tedoldi, S; Paterson, JC; Hansmann, ML; Natkunam, Y; Rüdiger, T; Angelisova, P; Du, MQ; (2006) Transmembrane adaptor molecules: a new category of lymphoid-cell markers. Blood , 107 (1) pp. 213-221. 10.1182/blood-2005-06-2273.

Teer, JK; Machida, YJ; Labit, H; Novac, O; Hyrien, O; Marheineke, K; Zannis-Hadjopoulos, M; (2006) Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation. J BIOL CHEM , 281 (10) 6253 - 6260. 10.1074/jbc.M507150200. Gold open access

Thompson, J; Lepikhova, T; Teixido-Travesa, N; Whitehead, MA; Palvimo, JJ; Jänne, OA; (2006) Small carboxyl-terminal domain phosphatase 2 attenuates androgen-dependent transcription. The EMBO Journal , 25 (12) pp. 2757-2767. 10.1038/sj.emboj.7601161.

Thomson, KJ; Mackinnon, S; (2006) Role of allogeneic transplantation in low-grade lymphoma and chronic lymphocytic leukemia. CURR OPIN HEMATOL , 13 (4) 273 - 279.

Thornton, AD; Ravn, P; Winslet, M; Chester, K; (2006) Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer. BRIT J SURG , 93 (12) 1456 - 1463. 10.1002/bjs.5624.

Tobar, JA; Carreno, LJ; Bueno, SM; Gonzalez, PA; Mora, JE; Quezada, SA; Kalergis, AM; (2006) Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. INFECT IMMUN , 74 (11) 6438 - 6448. 10.1128/IAI.00063-06.

Tolboom, TC; Zhang, YH; Henriquez, NV; Nelissen, RG; Toes, RE; Noteborn, MH; Huizinga, TW; (2006) Fibroblast-like synoviocytes from patients with rheumatoid arthritis are more sensitive to apoptosis induced by the viral protein, apoptin, than fibroblast-like synoviocytes from trauma patients. Clin Exp Rheumatol , 24 (2) pp. 142-147.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. NAT PROTOC , 1 (3) 1213 - 1222. 10.1038/nprot.2006.127.

Tolner, B; Smith, L; Begent, RHJ; Chester, KA; (2006) Production of recombinant protein in Pichia pastoris by fermentation. NAT PROTOC , 1 (2) 1006 - 1021. 10.1038/nprot.2006.126.

Tolner, B.; Smith, L.; Begent, R.H.J.; Chester, K.A.; (2006) Expanded-bed adsorption immobilized-metal affinity chromatography. Nature Protocols , 1 (3) pp. 1213-1222. 10.1038/nprot.2006.127.

Tolner, B.; Smith, L.; Begent, R.H.J.; Chester, K.A.; (2006) Production of recombinant protein in Pichia pastoris by fermentation. Nature Protocols , 1 (2) pp. 1006-1021. 10.1038/nprot.2006.126.

Tomita, K; Cooper, JP; (2006) The meiotic chromosomal bouquet: SUN collects flowers. Cell , 125 (1) pp. 19-21. 10.1016/j.cell.2006.03.020.

Traherne, JA; Horton, R; Roberts, AN; Miretti, M; Hurles, ME; Stewart, CA; Ashurst, JL; (2006) Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history. PLOS GENET , 2 (1) , Article e9. 10.1371/journal.pgen.0020009. Green open access

Tsolia, MN; Chapgier, A; Taprantzi, P; Servitzoglou, M; Tassios, I; Spyridis, N; Papageorgiou, F; (2006) Disseminated nontuberculous mycobacterial infection in a child with interferon-gamma receptor 1 deficiency. Eur J Pediatr , 165 (7) pp. 458-461. 10.1007/s00431-006-0110-7.


Vanhaesebroeck, B; (2006) Charging the batteries to heal wounds through PI3K. NATURE CHEMICAL BIOLOGY , 2 (9) pp. 453-455. 10.1038/nchembio0906-453.

Vaughan, B; Howard, J; Brazma, D; Nacheva, E; (2006) Loss of JAK2 in CML cell lines. In: (Proceedings) 48th Annual Meeting of the American-Society-of-Hematology. (pp. 287B-287B). AMER SOC HEMATOLOGY

Veeriah, S; Kautenburger, T; Habermann, N; Sauer, J; Dietrich, H; Will, F; Pool-Zobel, BL; (2006) Apple flavonoids inhibit growth of HT29 human colon cancer cells and modulate expression of genes involved in the biotransformation of xenobiotics. Mol Carcinog , 45 (3) pp. 164-174. 10.1002/mc.20158.

Veron, P; Boutin, S; Bernard, J; Danos, O; Davoust, J; Masurier, C; (2006) Efficient transduction of monocyte- and CD34+-derived Langerhans cells with lentiviral vectors in the absence of phenotypic and functional maturation. J Gene Med , 8 (8) pp. 951-961. 10.1002/jgm.923.

Vietri, M; Bianchi, M; Ludlow, JW; Mittnacht, S; Villa-Moruzzi, E; (2006) Direct interaction between the catalytic subunit of Protein Phosphatase 1 and pRb. Cancer Cell Int , 6 3-. 10.1186/1475-2867-6-3.

Vig, S; Chitolie, A; Bevan, D; Dormandy, J; Thompson, MM; Halliday, A; (2006) The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. BRIT J SURG , 93 (5) 577 - 581. 10.1002/bjs.5300.

Viviani, B; Gardoni, F; Bartesaghi, S; Corsini, E; Facchi, A; Galli, CL; Di Luca, M; (2006) Interleukin-1 beta released by gp120 drives neural death through tyrosine phosphorylation and trafficking of NMDA receptors. J BIOL CHEM , 281 (40) 30212 - 30222. 10.1074/jbc.M602156200. Gold open access

Vogt, G; Chapgier, A; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; Alcaïs, A; (2006) [Gains of glycosylation mutations]. Med Sci (Paris) , 22 (5) pp. 480-482. 10.1051/medsci/2006225480.

Vujovic, S; Henderson, S; Presneau, N; Odell, E; Jacques, TS; Tirabosco, R; Boshoff, C; (2006) Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J PATHOL , 209 (2) 157 - 165. 10.1002/path.1969.

Vukmanovic-Stejic, M; Zhang, Y; Cook, JE; Fletcher, JM; McQuaid, A; Masters, JE; Rustin, MHA; (2006) Human CD4(+)CD25(hi)Foxp3(+) regulatory T cells are derived by rapid turnover of memory populations in vivo. J CLIN INVEST , 116 (9) 2423 - 2433. 10.1172/JCI28941.


Wallace, DL; Berard, M; Soares, MVD; Oldham, J; Cook, JE; Akbar, AN; Tough, DF; (2006) Prolonged exposure of naive CD8(+) T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. IMMUNOLOGY , 119 (2) 243 - 253. 10.1111/j.1365-2567.2006.02429.x.

Walter, PB; Fung, EB; Killilea, DW; Jiang, Q; Hudes, M; Madden, J; Porter, J; (2006) Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease. BRIT J HAEMATOL , 135 (2) 254 - 263. 10.1111/j.1365-2141.2006.06277.x.

Ward, KN; Leong, HN; Nacheva, EP; Howard, J; Atkinson, CE; Davies, NWS; Griffiths, P; (2006) High level HHV-6 DNA and viral chromosomal integration. In: JOURNAL OF CLINICAL VIROLOGY. (pp. S31 - S31). ELSEVIER SCIENCE BV

Ward, KN; Leong, HN; Nacheva, EP; Howard, J; Atkinson, CE; Davies, NWS; Griffiths, PD; (2006) Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles. In: J CLIN MICROBIOL. (pp. 1571 - 1574). AMER SOC MICROBIOLOGY

Wells, G; Martin, CRH; Howard, PW; Sands, ZA; Laughton, CA; Tiberghien, A; Woo, CK; (2006) Design, synthesis, and biophysical and biological evaluation of a series of Pyrrolobenzodiazepine - Poly(N-methylpyrrole) conjugates. J MED CHEM , 49 (18) 5442 - 5461. 10.1021/jm051199z.

Westerman, M; Pizzey, A; Hirschman, J; Cerino, M; Well-Weiner, Y; Ramotar, P; Eze, A; (2006) Plasma hemoglobin: Potential sources. In: BLOOD. (pp. 29B - 29B). AMER SOC HEMATOLOGY

Whelan, J; Seddon, B; Perisoglou, M; (2006) Management of osteosarcoma. Curr Treat Options Oncol , 7 (6) pp. 444-455.

Whitaker, DC; Stygall, J; Harrison, MJG; Mackie, IJ; Kemp, M; Hooper, J; Pugsley, WB; (2006) Leucocyte-depleting arterial line filtration does not reduce myocardial injury assessed by Troponin T during routine coronary artery bypass grafting using crossclamp fibrillation. PERFUSION-UK , 21 (1) 55 - 60. 10.1191/0267659106pf847oa.

Wilkins, DK; Mayer, A; (2006) Development of antibodies for cancer therapy. EXPERT OPIN BIOL TH , 6 (8) 787 - 796. 10.1517/14712598.6.8.787.

Wilkins, DK; Mayer, A; (2006) Development of antibodies for cancer therapy. Expert Opinion on Biological Therapy , 6 (8) pp. 787-796. 10.1517/14712598.

Williams, RRE; Azuara, V; Perry, P; Sauer, S; Dvorkina, M; Jorgensen, H; Roix, J; (2006) Neural induction promotes large-scale chromatin reorganisation of the Mash1 locus. J CELL SCI , 119 (1) 132 - 140. 10.1242/jcs.02727.

Wittmann, J; Kocjan, G; Sgouros, SN; Deheragoda, M; Pereira, SP; (2006) Endoscopic ultrasound-guided tissue sampling by combined fine needle aspiration and trucut needle biopsy: a prospective study. CYTOPATHOLOGY , 17 (1) 27 - 33.

Woodhams, JH; MacRobert, AJ; Novelli, M; Bown, SG; (2006) Photodynamic therapy with WST09 (Tookad): Quantitative studies in normal colon and transplanted tumours. INT J CANCER , 118 (2) 477 - 482. 10.1002/ijc.21335.

Wortham, N.C.; (2006) Functional genetics of hereditary and sporadic uterine leiomyomas. Doctoral thesis, University of London. Green open access


Yau, T; Swanton, C; Chua, S; Sue, A; Walsh, G; Rostom, A; Johnston, SR; (2006) Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab. Acta Oncol , 45 (2) pp. 196-201. 10.1080/02841860500486630.


Zhang, JC; Hughes, SE; (2006) Role of the ephrin and Eph receptor tyrosine kinase (RTK) familes in angiogenesis of the cardiovascular system. The Journal of Pathology (208) pp. 453-461.

Zhao, Y; Thomas, HD; Batey, MA; Cowell, IG; Richardson, CJ; Griffin, RJ; Calvert, AH; (2006) Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441. CANCER RES , 66 (10) 5354 - 5362. 10.1158/0008-5472.CAN-05-4275.

This list was generated on Sun Jan 15 06:27:40 2017 GMT.